image
Technology - Information Technology Services - NYSE - GB
$ 5.09
0 %
$ 3.62 B
Market Cap
-2.57
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one CLVT stock under the worst case scenario is HIDDEN Compared to the current market price of 5.09 USD, Clarivate Plc is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one CLVT stock under the base case scenario is HIDDEN Compared to the current market price of 5.09 USD, Clarivate Plc is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one CLVT stock under the best case scenario is HIDDEN Compared to the current market price of 5.09 USD, Clarivate Plc is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
2.63 B REVENUE
-1.17%
-735 M OPERATING INCOME
81.28%
-911 M NET INCOME
76.99%
744 M OPERATING CASH FLOW
46.12%
-237 M INVESTING CASH FLOW
-414.31%
-496 M FINANCING CASH FLOW
34.60%
622 M REVENUE
-4.32%
21.7 M OPERATING INCOME
-67.66%
-65.6 M NET INCOME
78.44%
203 M OPERATING CASH FLOW
61.03%
-91.5 M INVESTING CASH FLOW
10.47%
-110 M FINANCING CASH FLOW
-331.89%
Balance Sheet Clarivate Plc
image
Current Assets 1.46 B
Cash & Short-Term Investments 371 M
Receivables 908 M
Other Current Assets 183 M
Non-Current Assets 11.2 B
Long-Term Investments 17.7 M
PP&E 107 M
Other Non-Current Assets 11.1 B
Current Liabilities 1.6 B
Accounts Payable 144 M
Short-Term Debt 48.8 M
Other Current Liabilities 1.41 B
Non-Current Liabilities 5.11 B
Long-Term Debt 4.78 B
Other Non-Current Liabilities 330 M
EFFICIENCY
Earnings Waterfall Clarivate Plc
image
Revenue 2.63 B
Cost Of Revenue 906 M
Gross Profit 1.72 B
Operating Expenses 2.46 B
Operating Income -735 M
Other Expenses 176 M
Net Income -911 M
RATIOS
65.52% GROSS MARGIN
65.52%
-27.95% OPERATING MARGIN
-27.95%
-34.66% NET MARGIN
-34.66%
-15.21% ROE
-15.21%
-7.17% ROA
-7.17%
-6.16% ROIC
-6.16%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Clarivate Plc
image
Net Income -911 M
Depreciation & Amortization 708 M
Capital Expenditures -242 M
Stock-Based Compensation 109 M
Change in Working Capital -60.4 M
Others 901 M
Free Cash Flow 502 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Clarivate Plc
image
Wall Street analysts predict an average 1-year price target for CLVT of $14.3 , with forecasts ranging from a low of $11 to a high of $20 .
CLVT Lowest Price Target Wall Street Target
11 USD 116.11%
CLVT Average Price Target Wall Street Target
14.3 USD 181.60%
CLVT Highest Price Target Wall Street Target
20 USD 292.93%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Clarivate Plc
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
1.38 M USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
17.9 M USD 1
0-3 MONTHS
1.64 M USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Nov 22, 2024
Bought 3.97 M USD
Angelakis Michael J
Director
+ 765000
5.19 USD
1 month ago
Nov 21, 2024
Bought 6.23 M USD
Angelakis Michael J
Director
+ 1200000
5.19 USD
1 month ago
Nov 20, 2024
Bought 7.67 M USD
Angelakis Michael J
Director
+ 1500000
5.11 USD
3 months ago
Oct 15, 2024
Sell 420 K USD
Veinstein Bar
President, A&G
- 60000
7 USD
4 months ago
Sep 19, 2024
Sell 840 K USD
Veinstein Bar
President, A&G
- 120000
7 USD
4 months ago
Aug 30, 2024
Sell 119 K USD
SAHA SAURABH
Director
- 17646
6.75 USD
5 months ago
Aug 09, 2024
Bought 1.49 M USD
Snyder Andrew Miles
Director
+ 262000
5.67 USD
5 months ago
Aug 08, 2024
Bought 159 K USD
Snyder Andrew Miles
Director
+ 28938
5.49 USD
2 years ago
Nov 15, 2022
Sell 1.05 M USD
Samson James Gordon
Chief Product Officer
- 100000
10.4811 USD
2 years ago
Sep 15, 2022
Bought 591 K USD
Snyder Andrew Miles
Director
+ 51063
11.58 USD
2 years ago
Sep 14, 2022
Bought 2.42 M USD
Snyder Andrew Miles
Director
+ 208333
11.61 USD
2 years ago
May 16, 2022
Sell 712 K USD
Samson James Gordon
Chief Product Officer
- 50000
14.2494 USD
2 years ago
May 11, 2022
Sell 111 K USD
Samson James Gordon
Chief Product Officer
- 8000
13.9177 USD
2 years ago
Mar 14, 2022
Sell 226 K USD
Samson James Gordon
Chief Product Officer
- 16000
14.13 USD
3 years ago
Jan 03, 2022
Sell 157 K USD
Samson James Gordon
President, IP Group
- 6400
24.4566 USD
3 years ago
Jan 03, 2022
Sell 37.6 K USD
Samson James Gordon
President, IP Group
- 1600
23.51 USD
3 years ago
Dec 08, 2021
Sell 362 K USD
Ahmed Mukhtar
President, Science Group
- 14578
24.8 USD
3 years ago
Nov 15, 2021
Sell 775 K USD
Samson James Gordon
President, IP Group
- 33000
23.4829 USD
3 years ago
Nov 16, 2021
Sell 792 K USD
Samson James Gordon
President, IP Group
- 33000
24 USD
3 years ago
Nov 04, 2021
Sell 600 K USD
Samson James Gordon
President, IP Group
- 25000
24 USD
3 years ago
Nov 01, 2021
Sell 581 K USD
Samson James Gordon
President, IP Group
- 25000
23.2303 USD
3 years ago
Nov 01, 2021
Sell 2.09 M USD
Samson James Gordon
President, IP Group
- 90000
23.2661 USD
3 years ago
Jun 14, 2021
Sell 266 M USD
ONEX CORP
10 percent owner
- 10562882
25.22 USD
3 years ago
Jun 14, 2021
Sell 266 M USD
Onex US Principals LP
10 percent owner
- 10562882
25.22 USD
3 years ago
Jun 11, 2021
Bought 500 K USD
ROEDEL RICHARD
Director
+ 19193
26.075 USD
3 years ago
Jun 14, 2021
Sell 13 M USD
von Blucher Sheryl G.
Director
- 500000
26 USD
3 years ago
Jun 14, 2021
Sell 2.33 M USD
Roy Jeff
President, IP Group
- 89648
26 USD
3 years ago
Jun 14, 2021
Sell 3.23 M USD
Hanks Richard
Chief Financial Officer
- 124297
26 USD
3 years ago
Mar 15, 2021
Sell 1.15 M USD
Ahmed Mukhtar
President, Science Group
- 43913
26.29 USD
3 years ago
Mar 11, 2021
Sell 1.95 M USD
Roy Jeff
President, IP Group
- 86050
22.7 USD
3 years ago
Mar 11, 2021
Sell 2.46 M USD
Ahmed Mukhtar
President, Science Group
- 107616
22.88 USD
3 years ago
Mar 12, 2021
Sell 968 K USD
Ahmed Mukhtar
President, Science Group
- 41573
23.28 USD
7. News
Clarivate Announces New $500 Million Share Repurchase Authorization LONDON , Dec. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (the "Board") authorized a new share repurchase program of up to $500 million of the Company's outstanding ordinary shares through open-market purchases for a period of two years, from January 1, 2025 through December 31, 2026. The new share repurchase program replaces the current share repurchase program which terminates December 31, 2024, under which the Company repurchased $300 million of ordinary shares, including $200 million during the third and fourth quarters of 2024. prnewswire.com - 1 month ago
Clarivate Launches AI-Powered Patent Search Solution in Derwent Faster and more relevant results to empower critical IP decision-making LONDON , Dec. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of AI Search in Derwent™. Combining artificial intelligence (AI) with the premier source of global patent data, Derwent World Patents Index (DWPI)™, this solution will enable intellectual property (IP) professionals to make reliable innovation decisions by finding more relevant patents in less time. prnewswire.com - 1 month ago
Bargains Galore? 3 Stocks With Insider Buying in the Millions It's widely believed that insiders know how well a company is operating. Therefore, when insiders are actively buying their stock, it is assumed they must know something that's motivating them to buy shares. marketbeat.com - 1 month ago
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts Revealing highly active specialties in sciences and social sciences LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy of Sciences (CAS) today released 2024 Research Fronts™, identifying the most dynamic and rapidly growing specialties in sciences and social sciences. This marks the eleventh annual collaboration between the two organizations, with the report launched at a ceremony held in Beijing today. prnewswire.com - 1 month ago
Daikin Selects IPfolio from Clarivate Enhancing operational efficiency for leading air conditioner manufacturer LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Daikin Industries, Ltd. (Daikin) has selected IPfolio™ from Clarivate. prnewswire.com - 1 month ago
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON , Nov. 21, 2024 /PRNewswire/ --  BioWorld ™ published by  Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the Health Divide. ' This seven-part series sheds light on the persistent disparities in women's health research, funding, and treatment. prnewswire.com - 1 month ago
Clarivate Reveals Highly Cited Researchers 2024 List Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON , Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. Analysts at the Institute for Scientific Information (ISI)™ have recognized 6,636 Highly Cited Researchers in 2024 from more than 1,200 institutions in 59 nations and regions. prnewswire.com - 2 months ago
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON , Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come . Over the past decade, Mainland China's biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches. prnewswire.com - 2 months ago
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON , Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year, the Revenue Cycle Awards recognize U.S.-based healthcare organizations for exceptional performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years. prnewswire.com - 2 months ago
Clarivate Publishes 2023 Sustainability Report LONDON , Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its commitment to sustainability and the United Nations Sustainable Development Goals (SDGs). In 2023, Clarivate was shortlisted for the SDG Pioneer Award at the Thomson Reuters Responsible Business Awards. prnewswire.com - 2 months ago
Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover I downgrade Clarivate PLC from buy to hold due to lack of confidence in near-term organic growth recovery and potential further stock price decline. CLVT's 3Q24 earnings report showed a 3.9% revenue decline and worsening organic growth, marking the worst performance in its history. The new CEO's Value Creation Plan is promising but will take a long time to show results, adding to the uncertainty. seekingalpha.com - 2 months ago
Clarivate Launches New Sustainability Research Solution ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research Assistant LONDON , Nov. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of ProQuestTM One Sustainability. The new solution is an expansive, curated, multi-format content collection designed to meet the growing demand for sustainability curricula across research, teaching and learning. prnewswire.com - 2 months ago
8. Profile Summary

Clarivate Plc CLVT

image
COUNTRY GB
INDUSTRY Information Technology Services
MARKET CAP $ 3.62 B
Dividend Yield 0.00%
Description Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Contact 70 St. Mary Axe, London, EC3A 8BE https://www.clarivate.com
IPO Date Oct. 29, 2018
Employees 12000
Officers Ms. Melanie D. Margolin J.D. Executive Vice President, Chief Administrative & Legal Officer and Secretary Mr. Michael Easton Senior Vice President of Finance & Chief Accounting Officer Mr. Mark J. Donohue CPA Head of Investor Relations Mr. William E. Graff Executive Vice President & Chief Information Officer Mr. Matti Shem Tov Chief Executive Officer & Director Mr. Gordon Samson President of Intellectual Property Mr. Bar Veinstein President of Academia & Government Ms. Tabita Andersson Senior Vice President of Communications & Brand Mr. Henry Levy President of Life Sciences & Healthcare Mr. Jonathan M. Collins Executive Vice President & Chief Financial Officer